Universe Pharmaceuticals INC Cost of Revenue
Universe Pharmaceuticals INC (UPC) reported Cost of Revenue of $11.56 billion for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-01-29
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $11.56B 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $16.95B 20-F · filed 2026-01-29 | $16.95M 20-F · filed 2025-04-29 | |
| 2024-03-31 | $9.52M 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $21.99B 20-F · filed 2026-01-29 | $21.99M 20-F · filed 2024-01-30 | |
| 2023-03-31 | $12.34M 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $18.25M 20-F · filed 2025-04-29 | ||
| 2022-03-31 | $10.45M 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $22.66M 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $12.30M 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $16.61M 20-F · filed 2023-02-10 | ||
| 2019-09-30 | $19.82M 20-F · filed 2022-01-31 |